Delivery Order SPE2DR25D3005-SPE2DR26FP8LC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,604.05 to AmerisourceBergen Drug Corp on December 11, 2025, for ACT-O-VIALS pharmaceutical products. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,298.24 to AmerisourceBergen Drug Corp on December 29, 2025, for ACT-O-VIALS, a pharmaceutical product. The contract is structured as firm fixed price with a completion deadline of December 30, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,968.60 firm fixed-price delivery order for ACT-O-VIALS with an ultimate completion date of December 22, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is classified as a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,969.92 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract performs at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,470.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for ACT-O-VIALS with an ultimate completion date of December 15, 2025. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,813.71 to AmerisourceBergen Drug Corp for ACT-O-VIALS, effective January 5, 2026, with completion by January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is being fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8LCDelivery Order
On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $19,433.50 to AmerisourceBergen Drug Corp for ACT-O-VIALS. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was awarded on a fully competitive basis with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and critical healthcare solutions provider for federal medical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support for military healthcare programs, covering a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and related medical supplies across multiple therapeutic domains. The contract supports critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 1/6/26 |